BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

196 related articles for article (PubMed ID: 25956189)

  • 1. Quality of life and symptom assessment in randomized clinical trials of bladder cancer: A systematic review.
    Feuerstein MA; Jacobs M; Piciocchi A; Bochner B; Pusic A; Fayers P; Blazeby J; Efficace F;
    Urol Oncol; 2015 Jul; 33(7):331.e17-23. PubMed ID: 25956189
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Patient-reported outcomes in randomised controlled trials of prostate cancer: methodological quality and impact on clinical decision making.
    Efficace F; Feuerstein M; Fayers P; Cafaro V; Eastham J; Pusic A; Blazeby J;
    Eur Urol; 2014 Sep; 66(3):416-27. PubMed ID: 24210091
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The future of Cochrane Neonatal.
    Soll RF; Ovelman C; McGuire W
    Early Hum Dev; 2020 Nov; 150():105191. PubMed ID: 33036834
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Patient-reported outcomes in randomised clinical trials of bladder cancer: an updated systematic review.
    Van Hemelrijck M; Sparano F; Josephs D; Sprangers M; Cottone F; Efficace F
    BMC Urol; 2019 Sep; 19(1):86. PubMed ID: 31521149
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Folic acid supplementation and malaria susceptibility and severity among people taking antifolate antimalarial drugs in endemic areas.
    Crider K; Williams J; Qi YP; Gutman J; Yeung L; Mai C; Finkelstain J; Mehta S; Pons-Duran C; Menéndez C; Moraleda C; Rogers L; Daniels K; Green P
    Cochrane Database Syst Rev; 2022 Feb; 2(2022):. PubMed ID: 36321557
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Patient-reported outcomes in randomised controlled trials of gynaecological cancers: investigating methodological quality and impact on clinical decision-making.
    Efficace F; Jacobs M; Pusic A; Greimel E; Piciocchi A; Kieffer JM; Gilbert A; Fayers P; Blazeby J;
    Eur J Cancer; 2014 Jul; 50(11):1925-41. PubMed ID: 24825114
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The level of patient-reported outcome reporting in randomised controlled trials of brain tumour patients: a systematic review.
    Dirven L; Taphoorn MJ; Reijneveld JC; Blazeby J; Jacobs M; Pusic A; La Sala E; Stupp R; Fayers P; Efficace F;
    Eur J Cancer; 2014 Sep; 50(14):2432-48. PubMed ID: 25034656
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Informative value of Patient Reported Outcomes (PRO) in Health Technology Assessment (HTA).
    Brettschneider C; Lühmann D; Raspe H
    GMS Health Technol Assess; 2011 Feb; 7():Doc01. PubMed ID: 21468289
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Patient-reported outcomes in head and neck and thyroid cancer randomised controlled trials: A systematic review of completeness of reporting and impact on interpretation.
    Mercieca-Bebber RL; Perreca A; King M; Macann A; Whale K; Soldati S; Jacobs M; Efficace F
    Eur J Cancer; 2016 Mar; 56():144-161. PubMed ID: 26851406
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Harnessing the patient voice in prostate cancer research: Systematic review on the use of patient-reported outcomes in randomized controlled trials to support clinical decision-making.
    Van Hemelrijck M; Sparano F; Moris L; Beyer K; Cottone F; Sprangers M; Efficace F
    Cancer Med; 2020 Jun; 9(12):4039-4058. PubMed ID: 32333639
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Patient-reported outcomes in randomised controlled trials of colorectal cancer: an analysis determining the availability of robust data to inform clinical decision-making.
    Rees JR; Whale K; Fish D; Fayers P; Cafaro V; Pusic A; Blazeby JM; Efficace F
    J Cancer Res Clin Oncol; 2015 Dec; 141(12):2181-92. PubMed ID: 25910987
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Intravesical Bacillus Calmette-Guérin with interferon-alpha versus intravesical Bacillus Calmette-Guérin for treating non-muscle-invasive bladder cancer.
    Shepherd AR; Shepherd E; Brook NR
    Cochrane Database Syst Rev; 2017 Mar; 3(3):CD012112. PubMed ID: 28268259
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Inclusion of older patients with cancer in randomised controlled trials with patient-reported outcomes: a systematic review.
    Sparano F; Aaronson NK; Sprangers MAG; Fayers P; Pusic A; Kieffer JM; Cottone F; Rees J; Pezold M; Anota A; Charton E; Vignetti M; Wan C; Blazeby J; Efficace F
    BMJ Support Palliat Care; 2019 Dec; 9(4):451-463. PubMed ID: 31719051
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Systematic Evaluation of Patient-Reported Outcome Protocol Content and Reporting in Cancer Trials.
    Kyte D; Retzer A; Ahmed K; Keeley T; Armes J; Brown JM; Calman L; Gavin A; Glaser AW; Greenfield DM; Lanceley A; Taylor RM; Velikova G; Brundage M; Efficace F; Mercieca-Bebber R; King MT; Turner G; Calvert M
    J Natl Cancer Inst; 2019 Nov; 111(11):1170-1178. PubMed ID: 30959516
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Quality of patient-reported outcome reporting in randomised controlled trials of haematological malignancies according to international quality standards: a systematic review.
    Chakraborty R; Cannella L; Cottone F; Efficace F
    Lancet Haematol; 2020 Dec; 7(12):e892-e901. PubMed ID: 33242446
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A rapid and systematic review of the clinical effectiveness and cost-effectiveness of topotecan for ovarian cancer.
    Forbes C; Shirran L; Bagnall AM; Duffy S; ter Riet G
    Health Technol Assess; 2001; 5(28):1-110. PubMed ID: 11701100
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Patterns of reporting health-related quality of life outcomes in randomized clinical trials: implications for clinicians and quality of life researchers.
    Brundage M; Bass B; Davidson J; Queenan J; Bezjak A; Ringash J; Wilkinson A; Feldman-Stewart D
    Qual Life Res; 2011 Jun; 20(5):653-64. PubMed ID: 21110123
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Incomplete reporting of patient-reported outcomes in multiple sclerosis: A meta-epidemiological study of randomized controlled trials.
    Khan T; Khalid M; Dunford B; Nguyen T; Wise A; Heigle B; Shepard S; Kee M; Hillman C; Ottwell R; Hartwell M; Vassar M
    Mult Scler Relat Disord; 2022 Jul; 63():103819. PubMed ID: 35487036
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Consolidated standards of reporting trials (CONSORT) and the completeness of reporting of randomised controlled trials (RCTs) published in medical journals.
    Turner L; Shamseer L; Altman DG; Weeks L; Peters J; Kober T; Dias S; Schulz KF; Plint AC; Moher D
    Cochrane Database Syst Rev; 2012 Nov; 11(11):MR000030. PubMed ID: 23152285
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Systematic Review of Radiation Therapy Toxicity Reporting in Randomized Controlled Trials of Rectal Cancer: A Comparison of Patient-Reported Outcomes and Clinician Toxicity Reporting.
    Gilbert A; Ziegler L; Martland M; Davidson S; Efficace F; Sebag-Montefiore D; Velikova G
    Int J Radiat Oncol Biol Phys; 2015 Jul; 92(3):555-67. PubMed ID: 26068490
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.